Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PCI Biotech Holding ASA (DE:4QG)
FRANKFURT:4QG
Holding DE:4QG?
Track your performance easily
4QG Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.09 - €0.23
Previous Close€0.15
Volume0.00
Average Volume (3M)3.75K
Market Cap
€5.51M
Enterprise Value-€69.25K
Total Cash (Recent Filing)kr67.22M
Total Debt (Recent Filing)kr1.43M
Price to Earnings (P/E)―
Beta0.02
Next Earnings
Nov 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume500
30 Day Avg. Volume3,750
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PCI Biotech Holding ASA News
PremiumCompany Announcements
PCI Biotech Sets Key Financial Dates for 2024-2025
PremiumCompany Announcements
PCI Biotech Awards Share Options to Executives
PremiumCompany Announcements
PCI Biotech’s Promising Mid-Year Technology Advances
PremiumCompany Announcements
PCI Biotech Schedules H1 2024 Interim Report Webcast4QG FAQ
What was PCI Biotech Holding ASA’s price range in the past 12 months?
PCI Biotech Holding ASA lowest stock price was €0.09 and its highest was €0.23 in the past 12 months.
What is PCI Biotech Holding ASA’s market cap?
Currently, no data Available
When is PCI Biotech Holding ASA’s upcoming earnings report date?
PCI Biotech Holding ASA’s upcoming earnings report date is Nov 13, 2024 which is in 53 days.
How were PCI Biotech Holding ASA’s earnings last quarter?
PCI Biotech Holding ASA released its earnings results on Aug 28, 2024. The company reported -€0.017 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.017.
Is PCI Biotech Holding ASA overvalued?
According to Wall Street analysts PCI Biotech Holding ASA’s price is currently Overvalued.
Does PCI Biotech Holding ASA pay dividends?
PCI Biotech Holding ASA does not currently pay dividends.
What is PCI Biotech Holding ASA’s EPS estimate?
PCI Biotech Holding ASA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PCI Biotech Holding ASA have?
PCI Biotech Holding ASA has 37,326,390 shares outstanding.
What happened to PCI Biotech Holding ASA’s price movement after its last earnings report?
PCI Biotech Holding ASA reported an EPS of -€0.017 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -13.333%.
Which hedge fund is a major shareholder of PCI Biotech Holding ASA?
Currently, no hedge funds are holding shares in DE:4QG
---
PCI Biotech Holding ASA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
PCI Biotech Holding ASA
PCI Biotech Holding ASA is a biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The PCI technology works by inducing light-triggered endosomal release. PCI is applied to three distinct anticancer paradigms; fimaCHEM which is an enhancement of chemotherapeutics for localized treatment of cancer, fimaVACC which is T-cell induction technology for therapeutic vaccination, and fimaNAc which is nucleic acid therapeutics delivery. Its therapeutic product candidate is the photosensitizer fimaporfin (Amphinex) which can unlock the intracellular capsules where active compounds are trapped.
---
Technical Analysis
---